Actively Recruiting
Al18F-NOTA-LM3 PET/CT in Patients With TIO
Led by Peking Union Medical College Hospital · Updated on 2026-01-26
40
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a pilot study to assess the value of whole-body Al18F-NOTA-LM3 PET/CT in patients with tumor-induced osteomalacia.
CONDITIONS
Official Title
Al18F-NOTA-LM3 PET/CT in Patients With TIO
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 to 80 years.
- Suspected or confirmed tumor-induced osteomalacia (TIO) patients.
You will not qualify if you...
- Presence of other types of tumors.
- Severe liver or kidney dysfunction (ALT/AST ≥5 times upper limit of normal, GFR <30 ml/min).
- Pregnant or breastfeeding women.
- Unable to undergo PET/CT scans.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730
Actively Recruiting
Research Team
H
Hongli Jing
CONTACT
Y
Yuwei Zhang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here